Pol, S., Corouge, M., & Vallet-Pichard, A. (2016). Daclatasvir–sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: From the clinical trials to real life. Hepat Med.
Stile di citazione ChicagoPol, Stanislas, Marion Corouge, e Anaïs Vallet-Pichard. "Daclatasvir–sofosbuvir Combination Therapy With or Without Ribavirin for Hepatitis C Virus Infection: From the Clinical Trials to Real Life." Hepat Med 2016.
Citazione MLAPol, Stanislas, Marion Corouge, e Anaïs Vallet-Pichard. "Daclatasvir–sofosbuvir Combination Therapy With or Without Ribavirin for Hepatitis C Virus Infection: From the Clinical Trials to Real Life." Hepat Med 2016.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.